StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report issued on Monday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Stock Performance
MDRX stock opened at $10.58 on Monday. Veradigm has a 1-year low of $5.01 and a 1-year high of $12.66. The business has a 50 day simple moving average of $9.75 and a two-hundred day simple moving average of $9.50.
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Where to Find Earnings Call Transcripts
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- How Can Investors Benefit From After-Hours Trading
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
